Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value:
$509.48M
Total Bought:
$509.48M
Total Sold:
$284.15M
Net Transaction:
+$225.33M
Notable People:
Sarah Elizabeth Monime
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Ambrx Biopharma Inc016,688,636+16,688,636$0$237.65M46.64%+$237.65M
TG Therapeutics, Inc.(TGTX)04,046,598+4,046,598$0$69.12M13.57%+$69.12M
MoonLake ImmunotherapeuticsCL A(MLTX)01,039,289+1,039,289$0$62.76M12.32%+$62.76M
Cytokinetics, Incorporated(CYTK)0600,000+600,000$0$50.09M9.83%+$50.09M
Keros Therapeutics, Inc.(KROS)01,060,427+1,060,427$0$42.16M8.28%+$42.16M
Vaxcyte, Inc.(PCVX)0579,959+579,959$0$36.42M7.15%+$36.42M
Springworks Therapeutics Inc0192,734+192,734$0$7.03M1.38%+$7.03M
Nuvalent Inc057,698+57,698$0$4.25M0.83%+$4.25M
AMBRX BIOPHARMA INCSPONSORED ADS16,688,6360-16,688,636$191.92M$0—-$191.92M
ARGENX SESPONSORED ADR(ARGX)45,6150-45,615$22.43M$0—-$22.43M
IMMUNOVANT INCCOM(IMVT)1,818,3710-1,818,371$69.81M$0—-$69.81M
Page 1 of 1